Translational Pharmacology Broadly Defined

Last Updated: 18 February 2016

Darrell R. Abernethy, MD, PhD
Editor-in-Chief

Andrew Lawrence, PhD
Deputy Editor-in-Chief
This virtual issue of Pharmacology Research & Perspectives is a nice representation of the breadth of outstanding contributions in the area of translational pharmacology that we receive and publish. Studies evaluating potential therapeutic targets including coagulation factor IXa, mitochondrial fission, intestinal immune response and serotonin receptors for obesity demonstrate the broad range of pharmacology we publish. Mechanisms of drug toxicity and their representation as clinical adverse drug effects are the counterpart of drug efficacy, and also areas that are represented. Finally, an important component of clinical translational pharmacology is the determination of drug exposure and optimal drug dose via reporting of pharmacokinetic, pharmacodynamic, and drug interaction studies. The articles in this virtual issue of Pharmacology Research & Perspectives should be of considerable interest to the translational pharmacologist, we believe you will find them of interest and value.
Brief Detailed

In Memoriam: Darrell R. Abernethy, M.D. Ph.D.

It is with deep sadness that the Editorial Team at PR&P must convey the news that Darrell Abernethy, Editor in Chief of the Journal, has recently passed away. Darrell has been instrumental in raising the profile and quality of PR&P in both his roles on the Journal, first as Deputy Editor and then Editor. He has been a true inspiration to so many of our authors and editors who work in the field of pharmacology, very much a team player, providing considered and thoughtful responses. His wise counsel will be missed.

Rest in peace

PR&P Editorial Team

Darrell's obituary can be viewed on the ASPET website